Metraipolis › archive › dc_80575ff03b7b

Comparative Clinical and Metabolic Outcomes of GLP-1 Receptor Agonists Versus SGLT2 Inhibitors in Type 1 Diabetes: A Retrospective Cohort Study from Saudi… — Europe PMC PMID:41691684

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41691684
DOI
10.2174/0115733998428827251223081042
License (as archived)
solo-consultazione
Archived
2026-11-07T03:36:39.787Z
SHA-256 of the archived text
4dcc776f2f1f6c1fd79852a51e54338e89458389fff20533123ebd5e63b5f9df
Stable URL of this page
https://metraipolis.com/documento/dc_80575ff03b7b

How to cite

Comparative Clinical and Metabolic Outcomes of GLP-1 Receptor Agonists Versus SGLT2 Inhibitors in Type 1 Diabetes: A Retrospective Cohort Study from Saudi… — Europe PMC PMID:41691684 — Europe PMC (en), https://europepmc.org/article/MED/41691684 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_80575ff03b7b (Metraipolis archive dc_80575ff03b7b, sha256 4dcc776f2f1f6c1fd79852a51e54338e89458389fff20533123ebd5e63b5f9df)
BibTeX
@misc{dc80575ff03b7b,
  title = {Comparative Clinical and Metabolic Outcomes of GLP-1 Receptor Agonists Versus SGLT2 Inhibitors in Type 1 Diabetes: A Retrospective Cohort Study from Saudi… — Europe PMC PMID:41691684},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41691684},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_80575ff03b7b; sha256 4dcc776f2f1f6c1fd79852a51e54338e89458389fff20533123ebd5e63b5f9df},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41691684. Agents can read the archived copy with the MCP tool read_document.